PPP2R1B gene in chronic lymphocytic leukemias and mantle cell lymphomas

Leukemia and Lymphoma

Volumn 41, Issue 1-2, 2001, Pages 177-183

  Zhu, Y ^a   Loukola, A ^a   Monni, O ^a   Kuokkanen, K ^a   Franssila, K ^a   Elonen, E ^a   Vilpo, J ^a   Joensuu, H ^a   Kere, J ^a   Aaltonen, L ^a   Knuutila, S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Chronic lymphocytic leukemia; Mantle cell lymphoma; Mutations; PPP2R1B gene

Indexed keywords

COMPLEMENTARY DNA; DNA; GENE PRODUCT; ISOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; RNA;

ARTICLE; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CHROMOSOME BAND; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; COLON CANCER; CONTROLLED STUDY; EXON; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENOME; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; PATHOGENESIS; PATHOGENICITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING;

EID: 0035069392     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109057968     Document Type: Article

References (30)

1. Optimized mitogen stimulation induces proliferation of neoplastic B-cells in chronic lymphocytic leukemia: Significance for cytogenetic analysis
2. Gain of 3q and deletion of 11q are frequent aberrations in mantle cell lymphoma
3. Frequent loss of the 11q14-q24 region in chronic lymphocytic leukemia: A study by comparative genomic hybridization
4. Loss of heterozygosity in sporadic human breast carcinoma: A common region between 11q22 and 11q23.3
5. Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer
6. 11q deletions in human colorectal carcinomas: Cytogenetics and restriction fragment length polymorphism analysis
7. Loss of heterozygosity in malignant melanoma at loci on chromosome 11 and 17 implicated in pathogenesis of other cancers
8. 11q23.1 and 11q25-qter YACs suppress tumour growth in vivo
9. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders
10. Molecular characterization of the deletion at 11q22.1-q23.3 in mantle cell lymphoma
11. Alterations of the PPP2R1B gene in human lung and colon cancer
12. INH, a negative regulator of MPF, is a form of protein phosphatase 2A
13. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells
14. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: The okadaic acid class of compounds
15. Polyoma small and middle T antigens and SV40 small antigen form stable complexes with protein phosphatase 2A
16. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation
17. HOX11 interacts with protein phosphatase PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint
18. Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha
19. Discontinuous deletions at chromosome band 11q23 in B-cell chronic lymphocytic leukemia
20. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples
21. Genomic organization and precise physical location of protein phosphatase 2A regulatory subunit A beta isoform gene on chromosome band 11q23
22. Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas
23. Absence of PPP2R1B gene alterations in primary ovarian cancers
24. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma
25. Mantle cell lymphoma is characterized by inactivation of the ATM gene
26. ATM Mutations in B-cell chronic lymphocytic leukemia
27. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia
28. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
29. A novel moesin-, ezrin-radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
30. Molecular cloning, cDNA sequence, and chromosomal assignment of the human radixin gene and two dispersed pseudogenes